Amgen Inc. (AMGN) research: valuation against peers, fundamentals over time, risk and news coverage
AMGN
Amgen Inc.No data in this window.
Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.
- BREAKING STORYBEARISHInsider Selling Cluster Widens Across Insurance, Biotech and Diagnostics
A concentrated day of Form 4 activity showed AIG's Zaffino selling over $18m, Guardant Health's CPO $7.6m, Amgen SVP $1.35m, Septerna's president/COO $1.1m, Red Cat director $310,600 and Knight-Swift director $115k, with only a token $4,612 buy at DLH Holdings on the other side.
Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.